Maverick Capital
Maverick Capital is a $10 billion hedge fund and has long been known as one of the largest and most consistently successful hedge funds. The fund was started in 1993 by Lee S. Ainslie III, who was a protege of Julian Robertson at Tiger Management. The fund only invests in equities and maintains a balance of long and short positions. The most common valuation method Maverick uses is comparing sustainable free cash flow to enterprise value. Maverick seeks to hold stocks between 1 and 3 years.
View Older Stories View More Recent Stories
-
Form 4 Infleqtion, Inc. For: Apr 10 Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13D Churchill Capital Corp Filed by: MAVERICK CAPITAL LTD
-
Form 3 Churchill Capital Corp For: Feb 13 Filed by: MAVERICK CAPITAL LTD
-
Form 13F-HR MAVERICK CAPITAL LTD For: Dec 31
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G/A PEABODY ENERGY CORP Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G/A ROCKET PHARMACEUTICALS, Filed by: MAVERICK CAPITAL LTD
-
Form 13F-HR MAVERICK CAPITAL LTD For: Sep 30
-
Form SCHEDULE 13G/A FRACTYL HEALTH, INC. Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G/A PEABODY ENERGY CORP Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G/A CURIS INC Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G PEABODY ENERGY CORP Filed by: MAVERICK CAPITAL LTD
-
Infleqtion agrees to go public via Churchill Capital merger
-
Form N-PX MAVERICK CAPITAL LTD For: Jun 30
-
Form 13F-HR MAVERICK CAPITAL LTD For: Jun 30
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G/A ROCKET PHARMACEUTICALS, Filed by: MAVERICK CAPITAL LTD
-
Form 13F-HR MAVERICK CAPITAL LTD For: Mar 31
-
Form SCHEDULE 13G ROCKET PHARMACEUTICALS, Filed by: MAVERICK CAPITAL LTD
-
Form 13F-HR MAVERICK CAPITAL LTD For: Dec 31
-
Form SCHEDULE 13G/A CURIS INC Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: MAVERICK CAPITAL LTD
-
Form SCHEDULE 13G/A Verona Pharma plc Filed by: MAVERICK CAPITAL LTD
-
Fiserv (FI) Appoints Michael P. Lyons as President and CEO-Elect
-
Cumulus Media (CMLS) Appoints Steven M. Galbraith to its Board
-
Form 13F-HR MAVERICK CAPITAL LTD For: Sep 30
-
Form SC 13G Verona Pharma plc Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A Invivyd, Inc. Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G FRACTYL HEALTH, INC. Filed by: MAVERICK CAPITAL LTD
-
Form N-PX MAVERICK CAPITAL LTD For: Jun 30
-
Form 13F-HR MAVERICK CAPITAL LTD For: Jun 30
-
GEN Restaurant Group (GENK) Appoints David Park to its Board of Directors
-
SDVerse Leverages Spryker to Drive the Future of Software-Defined Vehicles
-
SiMa.ai, Lanner, and AWL Collaborate to Accelerate Smart Retail at the Edge
-
Form 13F-HR MAVERICK CAPITAL LTD For: Mar 31
-
CDN Maverick Expands Footprint in James Bay & Provides Q1 Corporate Update
-
Thintronics Inc. Closes $23M Series A Financing Round Led by Maverick Capital and Translink Capital
-
Spryker Opens its Platform and Ushers in a New Era of Ecosystem-Driven Innovation
-
Auradine Raises $80 Million in Oversubscribed Series B Financing and Achieves $80 Million in Bookings
-
Spryker Appoints New Global Chief Revenue Officer
-
SiMa.ai, CVEDIA and Supermicro Announce Collaboration to Bring Smart City Solutions to the Edge
-
SiMa.ai, CVEDIA and Inventec Announce Partnership to Bring Smart Transportation Solutions to the Edge
-
SiMa.ai Secures Funds and Readies New Generative Edge AI Platform
-
Spryker Expands App Composition Platform with Stripe as its Global Payment Services Provider
-
Oula, the Modern Maternity Care Clinic Combining Midwifery and Obstetrics, Raises $28M in Series B Funding to Expand Nationally and Offer New Services
-
PNC Financial Services (PNC) Appoints Michael P. Lyons as President
-
PNC Appoints Michael P. Lyons President
-
Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors
-
Form SC 13G Invivyd, Inc. Filed by: MAVERICK CAPITAL LTD
-
Form 13F-HR MAVERICK CAPITAL LTD For: Dec 31
